Supal Pharmacare Profile
Key Indicators
- Authorised Capital ₹ 20.00 Cr
as on 07-07-2024
- Paid Up Capital ₹ 11.84 Cr
as on 07-07-2024
- Company Age 1 Year 5 Months
- Open Charges ₹ 4.75 Cr
as on 07-07-2024
About Supal Pharmacare
The Company is engaged in the Pharma Industry.
The Company's status is Active It's a company limited by shares with an authorized capital of Rs 20.00 Cr and a paid-up capital of Rs 11.84 Cr.
The company currently has active open charges totaling ₹4.75 Cr.
The Key Managerial Personnel (KMP) at Supal Pharmacare Limited India are Suchita Patel as CFO and Deepali Himani as Company Secretary. Archit Shah, Mitul Sapara, Panilamkumar Lakhatariya, and Two other members serve as directors at the Company.
- CIN/LLPIN
U47721GJ2023PLC142969
- Company No.
142969
- Company Classification
Public Limited Indian Non-Government Company
- Incorporation Date
17 Jul 2023
- Date of AGM
-
- Date of Balance Sheet
-
- Listing Status
Unlisted
- ROC Code
Roc Ahmedabad
Industry
Company Details
- Location
Ahmedabad, Gujarat, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Supal Pharmacare?
Executive Team (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Panilamkumar Lakhatariya  | Managing Director | 17-Jul-2023 | Current |
| Suchita Patel | CFO | Current | |
| Deepali Himani | Company Secretary | Current |
Board Members(4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Archit Shah | Director | 17-Jul-2023 | Current |
| Mitul Sapara | Director | 29-Feb-2024 | Current |
| Supal Lakhatariya | Director | 17-Jul-2023 | Current |
| Drashti Chande | Director | Current |
Financial Performance of Supal Pharmacare.
Enhance accessibility to Supal Pharmacare's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Supal Pharmacare?
Unlock access to Supal Pharmacare's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Mono Pharmacare LimitedActive 2 years 2 monthsArchit Shah, Panilamkumar Lakhatariya and 1 more are mutual person
- Supal Distributors LlpActive 8 years 29 days
Panilamkumar Lakhatariya and Supal Lakhatariya are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
The Cosmos Co Operative Bank Ltd Creation Date: 16 Oct 2021 | ₹4.75 Cr | Open |
How Many Employees Work at Supal Pharmacare?
Unlock and access historical data on people associated with Supal Pharmacare, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Supal Pharmacare, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Supal Pharmacare's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
